Fundz

Senti Biosciences to acquire Midco, paving the way for advanced cell therapies.

PUBLIC · SNTIOct 26, 2026

Acquiring Company

Senti Biosciences

Acquired Company

Midco

South San FranciscoSouth DakotaBiotechnologyHardwareVoip

Description

On October 21, 2026, Senti Biosciences Holdings, Inc. finalized the acquisition of Midco, marking a significant step in their development of CAR-NK cell therapies. This merger will enable Senti to streamline its operations and enhance its product offerings. A Contingent Value Rights Agreement was established, allowing for milestone-based cash payments contingent on product development achievements.

Who to call at Senti Biosciences, and when

When Senti Biosciences changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Senti Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Senti Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Senti Biosciences. With Fundz connected, it knows.

See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Senti Biosciences

Location

South San Francisco, California, United States

About

Senti Biosciences, Inc. is a biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Senti Biosciences makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Faraz
Likely contact at this company
••••••••@••••••••

See Faraz's verified email →

Faraz
Senior decision-maker at this company
••••••••@••••••••

See Faraz's verified email →

Thomas
Senior decision-maker at this company
••••••••@••••••••

See Thomas's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Senti Biosciences's next move

Learn about Strategic plan

Frequently asked

Who acquired Midco?

Midco was acquired by Senti Biosciences, based in South San Francisco. The deal was reported on October 26, 2026. Senti Biosciences, Inc. is a biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform. Senti Biosciences is publicly traded (SNTI) and operates in Biotechnology.

When did Senti Biosciences acquire Midco?

Senti Biosciences's acquisition of Midco was reported on October 26, 2026. On October 21, 2026, Senti Biosciences Holdings, Inc. finalized the acquisition of Midco, marking a significant step in their development of CAR-NK cell therapies. This merger will enable Senti to streamline its operations and enhance its product offerings. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Midco do?

Founded in 1931, Midco is a telecommunications leader redefining connectivity. We maintain market leadership by providing exceptional customer experiences using the region’s most reliable owned and operated fiber network spanning 17,000 miles. It is privately held, operating in Hardware, and is based in South Dakota.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.